Codexis (CDXS) Gross Profit Growth (1y) (2011 - 2026)
Codexis (CDXS) Gross Profit Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
75.94% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
7.76% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Codexis |
213.30 Mn |
148.16 Mn |
13.18 Mn |
174.04% |
| Date | Value |
|---|
| Mar 31, 2026 |
174.04% |
| Dec 31, 2025 |
107.08% |
| Sep 30, 2025 |
-27.95% |
| Jun 30, 2025 |
192.89% |
| Mar 31, 2025 |
-60.62% |
| Dec 31, 2024 |
732.83% |
| Sep 30, 2024 |
21.17% |
| Jun 30, 2024 |
147.91% |
| Mar 31, 2024 |
44.40% |
| Dec 31, 2023 |
-81.15% |
| Sep 30, 2023 |
-71.53% |
| Jun 30, 2023 |
-93.29% |
| Mar 31, 2023 |
-68.45% |
| Dec 31, 2022 |
-35.89% |
| Sep 30, 2022 |
-17.45% |
| Jun 30, 2022 |
28.39% |
| Mar 31, 2022 |
94.14% |
| Dec 31, 2021 |
16.62% |
| Sep 30, 2021 |
102.82% |
| Jun 30, 2021 |
59.29% |
